# Black Canyon Bio jobs and careers

> 0 open roles at Black Canyon Bio as of October 23, 2026. Source: https://www.thejobsmap.com/company/black-canyon-bio

Black Canyon Bio (BCB) is developing novel products for treating cancer using our proprietary Specific Neo-Antigen Peptides (SNAP) Technology platform. SNAP Technology has product development applications across many cancers and other diseases. SNAP Technology was developed by Dr. Sunil Sharma and his team at the Translational Genomics Research Institute (TGen), part of the City of Hope Medical Network, where Dr. Sharma is a Deputy Director of Clinical Sciences and Professor and Division Director of Applied Cancer Research and Drug Discovery, and directs the City of Hope Center for Cancer Prevention and Early Detection. BCB’s first two products, SNAP-Vac (a personalized cancer vaccine) and SNAP-TIL (a personalized cellular therapy) will start human clinical testing in 2024. The market for cancer vaccines and cellular therapies is expected to grow exponentially during the next decade, and these SNAP-based cancer treatments have the potential to be leading products.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Employees | 1 to 10 |
| Industries | Biotechnology, Health Care, Therapeutics |
| Website | https://blackcanyonbio.com |

## Leadership

- Kenneth Carter, Co-founder And Executive Chairman

## Common questions

### Is Black Canyon Bio hiring right now?

Black Canyon Bio has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Black Canyon Bio's careers site.

### Who leads Black Canyon Bio?

Kenneth Carter, Co-founder And Executive Chairman, is at the top of Black Canyon Bio's org chart.

### How do I apply for a job at Black Canyon Bio?

Pick a role on Black Canyon Bio's TheJobsMap page and select Apply. Every listing links to the original posting on Black Canyon Bio's own careers site, so you apply directly with the employer.